2006Zhongguo linchuang baojian zazhiRequires access

Trimebutine maleate in combination with bifidobacteria in the treatment of irritable bowel syndrome

Hong Qiao

Open publisher page 0 citations

Abstract

Objective To compare the curative effect of trimebutine maleate in combination with Bifid.With that of trimebutine maleate alone in the treatment of irritable bowel syndrome(IBS).Methods 96 patients with IBS were randomly divided into two groups.50 patients of the treatment group were given each 200mg of trimebutine maleate,po,t.i.d.and two pills of Bifid every day.Triple viable power,po,t.i.d;46 patients of the control group were given 200 mg of trimebutine maleate alone,po,t.i.d.The course of treatment in both groups lasted for 4 weeks.Results The curative effect in the treatment group was 94%,while that of the control group was only 78%(P0.05).the effect of remitting abdominal distension,diarrhea in the treatment group were much better than those of the control group.Conclusion Trimebutine maleate in combination with bifid triple viable power is effective in the treatment of IBS.

About this research paper

What this paper is about

Objective To compare the curative effect of trimebutine maleate in combination with Bifid.With that of trimebutine maleate alone in the treatment of irritable bowel syndrome(IBS).Methods 96 patients with IBS were randomly divided into two groups.50 patients of the treatment group were given each 200mg of trimebutine maleate,po,t.i.d.and two pills of Bifid every day.Triple viable power,po,t.i.d;46 patients of the control group were given 200 mg of trimebutine maleate alone,po,t.i.d.The course of treatment in both groups lasted for 4 weeks.Results The curative effect in the treatment group was 94%,while that of the control group was only 78%(P0.05).the effect of remitting abdominal distension,diarrhea in the treatment group were much better than those of the control group.Conclusion Trimebutine maleate in combination with bifid triple viable power is effective in the treatment of IBS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the curative effect of trimebutine maleate in combination with Bifid.With that of trimebutine maleate alone in the treatment of irritable bowel syndrome(IBS).Methods 96 patients with IBS were randomly divided into two groups.50 patients of the treatment group were given each 200mg of trimebutine maleate,po,t.i.d.and two pills of Bifid every day.Triple viable power,po,t.i.d;46 patients of the control group were given 200 mg of trimebutine maleate alone,po,t.i.d.The course of treatment in both groups lasted for 4 weeks.Results The curative effect in the treatment group was 94%,while that of the control group was only 78%(P0.05).the effect of remitting abdominal distension,diarrhea in the treatment group were much better than those of the control group.Conclusion Trimebutine maleate in combination with bifid triple viable power is effective in the treatment of IBS.

Key concepts: Medicine, Irritable bowel syndrome, Diarrhea, Pill, Gastroenterology, Internal medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Trimebutine maleate in combination with bifidobacteria in the treatment of irritable bowel syndrome — Research Paper | ScholarLens